β-Nicotinamide Mononucleotide-13C5

CAS: 1094-61-7

Ref. TR-N407767

Produktinformation

• Name: β-Nicotinamide Mononucleotide-13C5
• Synonyme: [(2R,3R,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy(2,3,4,5-13C4)oxolan-2-yl](113C)methyl hydrogen phosphate
• Marke: TRC
• Beschreibung: Applications The labelled analogue of a product of the extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) reaction and a key NAD+ intermediate. It ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. It also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation.References Yoshino, J. et al.: Cell Metab., 14, 528 (2011); Caton, P.W. et al.: Diabetologia, 54, 3083 (2011); Formentini, L. et al.: BIochem. Pharmacol., 77, 1612 (2009)

Chemische Eigenschaften

• Molekulargewicht: 339.182
• Formel: C₅C₆H₁₅N₂O₈P
• Farbe/Form: Neat
• InChl: InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8+,9-,11-/m1/s1/i5+1,7+1,8+1,9+1,11+1
• SMILES: NC(=O)c1ccc[n+]([13C@@H]2O[13C@H]([13CH2]OP(=O)([O-])O)[13C@H](O)[13C@H]2O)c1